Diabetes Devices And Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Diabetes occurs when blood glucose, also called blood sugar, is too high. Insulin, a hormone made by the pancreas, helps glucose from food get into cells to be used for energy. There are various drugs and devices that help to monitor the blood glucose level. Devices such as Blood Glucose, meters and strips, continuous glucose monitors (CGMs), injection Pens for Insulin and GLP-1 Agonists, insulin pumps, and others are most commonly used.

MARKET DYNAMICS

Growing prevalence of diabetes with rising obesity rates, changing lifestyle and dietary habits, growing ageing population, and growing minimally invasive insulin delivery devices are the major drivers to propel the growth of this market.

MARKET SCOPE

The "Diabetes Devices and Drugs Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of diabetes devices and drugs market with detailed market segmentation by devices and drugs. The diabetes devices and drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in diabetes devices and drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The diabetes devices and drugs market is segmented on the devices and drugs. Based on devices, the market is segmented as continuous blood glucose monitoring devices, test strips, self-monitoring devices, insulin delivery devices, and others. Based on drugs, the market is segmented as insulin, oral hypoglycaemic agents, and non-insulin injectable.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the diabetes devices and drugs market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The diabetes devices and drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting diabetes devices and drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the diabetes devices and drugs market in these regions.

MARKET PLAYERS

The report covers key developments in the diabetes devices and drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from diabetes devices and drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for diabetes devices and drugs in the global market. Below mentioned is the list of few companies engaged in the diabetes devices and drugs market.

The report also includes the profiles of key players in diabetes devices and drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•  NOVO NORDISK A/S
  
•  YPSOMED AG
  
•  ABBOTT LABORATORIES
  
•  ASCENSIA DIABETES CARE HOLDINGS AG
  
•  ELI LILLY AND COMPANY
  
•  HOFFMANN-LA ROCHE LTD
  
•  JOHNSON AND JOHNSON
  
•  MEDTRONIC PLC.
  
•  BECTON, DICKINSON AND COMPANY
  
•  TERUMO CORPORATION
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Diabetes Devices And Drugs Report Scope